|
Jul 17
|
Down 6.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Alvotech (ALVO)
|
|
Jul 16
|
Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group
|
|
Jul 10
|
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
|
|
Jul 9
|
Alvotech expands biosimilars capabilities with Ivers-Lee acquisition
|
|
Jul 9
|
Exchange-Traded Fund, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Meeting Minutes
|
|
Jul 9
|
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland
|
|
Jul 9
|
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
|
|
Jul 6
|
Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma
|
|
Jul 1
|
Granting of Stock Options and Vesting of Restricted Share Units
|
|
Jul 1
|
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
|
|
Jun 27
|
Exploring 3 High Growth Tech Stocks in the US Market
|
|
Jun 26
|
Alvotech, Kashiv, Advanz announce study of AVT23 met primary endpoint
|
|
Jun 26
|
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
|
|
Jun 25
|
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Easing Middle East Tensions
|
|
Jun 25
|
US High Growth Tech Stocks To Watch In June 2025
|
|
Jun 25
|
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
|
|
Jun 24
|
High Growth Tech Stocks To Watch In US June 2025
|
|
Jun 24
|
Exploring US High Growth Tech Stocks To Watch In June 2025
|
|
Jun 23
|
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
|
|
Jun 11
|
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
|